This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 2849

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Energy Deposition leads to Bone Loss

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Deposition of energy leading to occurrence of bone loss non-adjacent High Moderate Cataia Ives (send email) Open for citation & comment

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
human Homo sapiens High NCBI
mouse Mus musculus High NCBI
rat Rattus norvegicus Moderate NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help
Sex Evidence
Male High
Female Moderate
Unspecific Moderate

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help
Term Evidence
Adult High
Juvenile Moderate

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

Energy deposited onto an organism from ionizing radiation (IR) can result in an increase in bone loss. Bone loss refers to a decrease in bone mass or density as observed in a variety of conditions such as osteopenia and osteoporosis (Cummings, Bates, and Black, 2002). Energy deposition can interfere with overall bone integrity and the capacity to withstand mechanical load, leading to an increased risk of fractures (Cummings, Bates, and Black, 2002; Willey et al., 2011). Ionizing energy deposited into an organism is absorbed eliciting breakage of water molecules leading to free radical formation, if this overwhelms the antioxidant capacity, then oxidative stress ensues. If this occurs in bone tissue cells, including osteoblasts, osteoclasts, and osteocytes, it can dysregulate their activity. The subsequent increases in bone resorption and decreases in bone formation culminate in increased bone loss. Bone loss can be induced by a variety of radiation sources, including low linear energy transfer (LET) radiation, such as X-rays, gamma rays, and protons, and high LET radiation, such as heavy ions, at a wide range of doses and dose rates. IR-induced bone loss can be observed through microarchitectural measurements that show the structural deterioration of affected bones.

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

The strategy for collating the evidence on radiation stressors to support the relationship is described in Kozbenko et al 2022. Briefly, a scoping review methodology was used to prioritize studies based on a population, exposure, outcome, endpoint statement.

Evidence Map 2.0

ID Experimental Design Species Upstream Observation Downstream Observation Citation (first author, year) Notes

Evidence Map

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Title First Author
Biological Plausibility
Dose Concordance
Temporal Concordance
Incidence Concordance
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help
  • At 8 days post-16 Gy irradiation, there was a significant increase in trabecular BV/TV relative to the non-irradiated controls, contrary to the expected reduction in bone volume usually seen following energy deposition (Hui et al., 2014). 

  • When exposed to 0.1, 0.5, and 2 Gy of 56Fe heavy ions, mice did not follow the expected dose-dependent response. Compared to non-irradiated controls, 0.1 and 0.5 Gy irradiation resulted in significant 16% and 18% decreases in BV/TV, respectively. 2 Gy radiation did not have a significant effect on trabecular BV/TV. 0.1 and 0.5 Gy irradiation similarly decreased Tb.N by 7% and 5%, respectively, while changes following 2 Gy irradiation were non-significant (Yumoto et al., 2010). 

  • Many clinical studies demonstrate that bone loss occurs following radiotherapy in humans (Willey et al., 2011). However, very few studies specify the dose of radiation used, reducing the availability of human studies and an understanding of dose-effects. 

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help

Modulating Factor 

MF details 

Effects on the KER 

References 

Drug 

Risedronate 

Led to restored BV/TV and Conn. D levels after radiation. 

Willey et al., 2010 

Genotype 

Loss of function mutations (like in sclerosteosis and van Buchem disease) in the SOST gene for sclerostin (sclerostin is a Wnt receptor antagonist that inhibits osteoclastogenesis). 

Radiation did not affect BMD and BV/TV in sclerostin knockout mice. 

Chandra et al., 2017 

Drug 

1–34 amino-terminal fragment of parathyroid hormone (osteoporosis treatment that attenuates osteoblast apoptosis). 

Treatment with 60 µg/kg/day for 27 days led to increased BV/TV and BMD after radiation-induced decreases. 

Chandra et al., 2014 

Age 

Old age 

Lower estrogen at old age is thought to contribute to the detrimental effects of radiotherapy on bone loss in elderly patients. 

Pacheco and Stock, 2013 

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

Evidence for this relationship is from human, mice, and rat models, with considerable available evidence in mice and humans. The relationship is well supported in both males and females using in vivo models. There is in vivo evidence from studies conducted using preadolescent, adolescent, and adult rodent models.